To access this element change to forms mode OFF
Grant Award View - GA282059
Customised exosomes - the future of regenerative medicine
GA ID:
GA282059
Agency:
Department of Industry, Science and Resources
Approval Date:
5-Jan-2023
Publish Date:
6-Feb-2023
Category:
Industry Innovation
Grant Term:
3-Feb-2023 to 9-Jun-2026
Value (AUD):
$3,297,495.30
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DISR 22/23 Investing in science, technology and commercialisation
Grant Program:
Cooperative Research Centres Programme
Grant Activity:
Customised exosomes - the future of regenerative medicine
Purpose:
Grant funding will support the establishment of an exosome manufacturing facility in Australia and optimise technologies and processes for manufacture of exosomes. Exosomes have potential to be an off-the-shelf, cell-based pharmaceutical for various diseases without the technical challenges of cell therapies. The project will use multiple strategies to produce unique, customised exosomes with enhanced functional attributes and generate proof of concept data for specific clinical indications in therapeutic areas of significant unmet need (ophthalmic and neurological).
GO ID:
GO Title:
Cooperative Research Centres Projects - Round 13
Internal Reference ID:
CRCPXIII000069
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
VIVAZOME THERAPEUTICS PTY LTD
Recipient ABN:
59 602 230 964
Grant Recipient Location
Suburb:
BELMONT
Town/City:
BELMONT
Postcode:
3216
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3168
Country:
AUSTRALIA